Future-proofing tuberculosis therapy: framework for concurrent drug and resistance testing development.

Saved in:
Bibliographic Details
Title: Future-proofing tuberculosis therapy: framework for concurrent drug and resistance testing development.
Authors: Saluzzo F; Vita Salute San Raffaele University, Milan, Italy; IRCCS San Raffaele Scientific Institute, Department of Immunology, Transplantation and Infectious Diseases, Milan, Italy., Yerlikaya S; Department of Infectious Disease and Tropical Medicine, University Hospital Heidelberg, Heidelberg, Germany; German Centre for Infectious Disease Research, DZIF Partner Site Heidelberg, Heidelberg, Germany., Dorman SE; Medical University of South Carolina, Charleston, SC, USA., Eisenach K; TB or NOT TB Consulting, Little Rock, AR, USA., Farhat MR; Department of Biomedical Informatics, Harvard Medical School, Boston, MA, USA., Ismail N; Department of Clinical Microbiology and Infectious Diseases, National Health Laboratory Service, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., Lienhardt C; Unité Mixte Internationale TransVIHMI, Institut de Recherche pour le Développement (IRD), Université de Montpellier, Montpellier, France; Epidemiology and Population Health, Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK., Walker TM; Oxford University Clinical Research Unit, Ho Chi Minh City, Viet Nam; Nuffield Department of Medicine, University of Oxford, Oxford, UK., Jones F; Division of AIDS, National Institutes of Health, Rockville, MD, USA., Yepes A; Global Health Medicines Research and Development, GlaxoSmithKline, Madrid, Spain., Penn-Nicholson A; FIND, Geneva, Switzerland., Ruhwald M; FIND, Geneva, Switzerland., Kana B; School of Pathology, Infectious Diseases and Oncology Research Institute, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., Denkinger CM; Heidelberg University Hospital, INF 324, Heidelberg, Germany., Cirillo DM; IRCCS San Raffaele Scientific Institute, Department of Immunology, Transplantation and Infectious Diseases, Milan, Italy. Electronic address: cirillo.daniela@hsr.it.
Source: The Lancet. Infectious diseases [Lancet Infect Dis] 2026 Jun; Vol. 26 (6), pp. e248-e256. Date of Electronic Publication: 2025 Oct 23.
Publication Type: Journal Article; Review
Journal Info: Publisher: Elsevier Science Country of Publication: United States NLM ID: 101130150 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-4457 (Electronic) Linking ISSN: 14733099 NLM ISO Abbreviation: Lancet Infect Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1474-4457
DOI:10.1016/S1473-3099(25)00547-X